You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ANASTROZOLE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Anastrozole patents expire, and when can generic versions of Anastrozole launch?

Anastrozole is a drug marketed by Accord Hlthcare, Apotex Inc, Beijing Yiling, Chartwell Molecular, Chartwell Rx, Cipla, Eugia Pharma, Fresenius Kabi Usa, Hikma, Impax Labs Inc, Kenton, Natco Pharma Ltd, Norvium Bioscience, Sandoz, Sun Pharm Inds Ltd, Synthon Pharms, Teva Pharms, Watson Labs Teva, and Zydus Pharms Usa Inc. and is included in nineteen NDAs.

The generic ingredient in ANASTROZOLE is anastrozole. There are twenty-four drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the anastrozole profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Anastrozole

A generic version of ANASTROZOLE was approved as anastrozole by ACCORD HLTHCARE on June 28th, 2010.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ANASTROZOLE?
  • What are the global sales for ANASTROZOLE?
  • What is Average Wholesale Price for ANASTROZOLE?
Drug patent expirations by year for ANASTROZOLE
Drug Prices for ANASTROZOLE

See drug prices for ANASTROZOLE

Drug Sales Revenue Trends for ANASTROZOLE

See drug sales revenues for ANASTROZOLE

Recent Clinical Trials for ANASTROZOLE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Breast Cancer Research FoundationPhase 2
University of Wisconsin, MadisonPhase 2
Verastem, Inc.Phase 3

See all ANASTROZOLE clinical trials

Pharmacology for ANASTROZOLE
Drug ClassAromatase Inhibitor
Mechanism of ActionAromatase Inhibitors

US Patents and Regulatory Information for ANASTROZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare ANASTROZOLE anastrozole TABLET;ORAL 090568-001 Jun 28, 2010 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs Teva ANASTROZOLE anastrozole TABLET;ORAL 078984-001 Jun 28, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Eugia Pharma ANASTROZOLE anastrozole TABLET;ORAL 212434-001 Jul 24, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Molecular ANASTROZOLE anastrozole TABLET;ORAL 091331-001 Jan 5, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Natco Pharma Ltd ANASTROZOLE anastrozole TABLET;ORAL 079220-001 Jun 28, 2010 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa ANASTROZOLE anastrozole TABLET;ORAL 090088-001 Jun 28, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms Usa Inc ANASTROZOLE anastrozole TABLET;ORAL 078921-001 Jun 28, 2010 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.